These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

961 related articles for article (PubMed ID: 9135515)

  • 21. CagA seropositivity associated with development of gastric cancer in a Japanese population.
    Shimoyama T; Fukuda S; Tanaka M; Mikami T; Munakata A; Crabtree JE
    J Clin Pathol; 1998 Mar; 51(3):225-8. PubMed ID: 9659265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune response to a recombinant fragment of the CagA protein of Helicobacter pylori in blood donors and patients with gastric cancer: relation to ABO(H) blood group phenotype, stage of the disease and tumor morphology.
    Klaamas K; Kurtenkov O; Covacci A; Lipping A; Wadström T
    Med Microbiol Immunol; 1999 May; 187(4):227-32. PubMed ID: 10363680
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clostridium difficile-associated disease and Helicobacter pylori seroprevalence: A case-control study.
    Muhsen K; Na'amnih W; Adler A; Carmeli Y; Cohen D
    Helicobacter; 2020 Feb; 25(1):e12668. PubMed ID: 31721371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of bacterial CagA status on gastritis, gastric function indices, and pattern of symptoms in H. pylori-positive dyspeptic patients.
    Parente F; Imbesi V; Maconi G; Cucino C; Sangaletti O; Vago L; Bianchi Porro G
    Am J Gastroenterol; 1998 Jul; 93(7):1073-9. PubMed ID: 9672333
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating anti-Helicobacter pylori immunoglobulin A antibodies and low serum pepsinogen I level are associated with increased risk of gastric cancer.
    Aromaa A; Kosunen TU; Knekt P; Maatela J; Teppo L; Heinonen OP; Härkönen M; Hakama MK
    Am J Epidemiol; 1996 Jul; 144(2):142-9. PubMed ID: 8678045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low-positive antibody titer against Helicobacter pylori cytotoxin-associated gene A (CagA) may predict future gastric cancer better than simple seropositivity against H. pylori CagA or against H. pylori.
    Suzuki G; Cullings H; Fujiwara S; Hattori N; Matsuura S; Hakoda M; Akahoshi M; Kodama K; Tahara E
    Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1224-8. PubMed ID: 17548689
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Seroprevalence of
    Fernandez-Botran R; Wellmann IA; Une C; Méndez-Chacón E; Hernández de Rodas E; Bhandari B; Villagrán de Tercero CI
    Am J Trop Med Hyg; 2020 Jul; 103(1):260-265. PubMed ID: 32314688
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Helicobacter pylori infection and low serum pepsinogen I level as risk factors for gastric carcinoma.
    Kokkola A; Louhimo J; Puolakkainen P; Alfthan H; Haglund C; Rautelin H
    World J Gastroenterol; 2005 Feb; 11(7):1032-6. PubMed ID: 15742409
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Helicobacter pylori and atrophic gastritis: importance of the cagA status.
    Kuipers EJ; Pérez-Pérez GI; Meuwissen SG; Blaser MJ
    J Natl Cancer Inst; 1995 Dec; 87(23):1777-80. PubMed ID: 7473834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Helicobacter pylori infection and markers of gastric cancer risk in Alaska Native persons: a retrospective case-control study.
    Keck JW; Miernyk KM; Bulkow LR; Kelly JJ; McMahon BJ; Sacco F; Hennessy TW; Bruce MG
    Can J Gastroenterol Hepatol; 2014 Jun; 28(6):305-10. PubMed ID: 24945184
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histology and culture results among subjects with antibodies to CagA but no evidence of Helicobacter pylori infection with IgG ELISA.
    Ye W; Held M; Enroth H; Kraaz W; Engstrand L; Nyrén O
    Scand J Gastroenterol; 2005 Mar; 40(3):312-8. PubMed ID: 15932172
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of gastric carcinoma risk associated with Helicobacter pylori may vary depending on the antigen used: CagA specific enzyme-linked immunoadsorbent assay (ELISA) versus commercially available H. pylori ELISAs.
    Maeda S; Yoshida H; Ogura K; Yamaji Y; Ikenoue T; Mitsushima T; Tagawa H; Kawaguchi R; Mori K; Mafune Ki; Kawabe T; Shiratori Y; Omata M
    Cancer; 2000 Apr; 88(7):1530-5. PubMed ID: 10738209
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Helicobacter pylori infection in two areas in Japan with different risks for gastric cancer.
    Nobuta A; Asaka M; Sugiyama T; Kato M; Hige S; Takeda H; Kato T; Ogoshi K; Keida Y; Shinomura J
    Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():1-6. PubMed ID: 15298598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IgG2 response and low IgG titre specific to Helicobacter pylori CagA as serological markers for gastric cancer.
    de la Cruz-Herrera CF; Flores-Luna L; Gutierrez-Xicotencatl L; Chihu-Amparan L; Sánchez-Aleman MA; Lazcano-Ponce E; Torres J; Ayala G
    J Med Microbiol; 2013 Apr; 62(Pt 4):591-598. PubMed ID: 23288428
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Helicobacter pylori infection and gastroesophageal reflux in a population-based study (The HUNT Study).
    Nordenstedt H; Nilsson M; Johnsen R; Lagergren J; Hveem K
    Helicobacter; 2007 Feb; 12(1):16-22. PubMed ID: 17241296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
    Kowalski M
    J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum levels of high-sensitivity C-reactive protein (hs-CRP)in Helicobacter pylori-infected peptic ulcer patients and its association with bacterial CagA virulence factor.
    Jafarzadeh A; Hassanshahi GH; Nemati M
    Dig Dis Sci; 2009 Dec; 54(12):2612-6. PubMed ID: 19160050
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation of anti-Helicobacter pylori cagA IgG antibodies with resistance to first line treatment, bleeding gastroduodenal ulcers and gastric cancer.
    Ilie M; Dascălu L; Chifiriuc C; Popa M; Constantinescu G; Tănăsescu C; Baltac A
    Roum Arch Microbiol Immunol; 2011; 70(3):101-4. PubMed ID: 22570922
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of Helicobacter pylori CagA+ strains and risk of adenocarcinoma of the stomach and esophagus.
    Wu AH; Crabtree JE; Bernstein L; Hawtin P; Cockburn M; Tseng CC; Forman D
    Int J Cancer; 2003 Mar; 103(6):815-21. PubMed ID: 12516104
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Helicobacter pylori IgA and IgG antibodies, serum pepsinogen I and the risk of gastric cancer: changes in the risk with extended follow-up period.
    Knekt P; Teppo L; Aromaa A; Rissanen H; Kosunen TU
    Int J Cancer; 2006 Aug; 119(3):702-5. PubMed ID: 16496404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 49.